Literature DB >> 11723196

Multiple sclerosis in sibling pairs: an analysis of 250 families.

J Chataway1, A Mander, N Robertson, S Sawcer, J Deans, M Fraser, S Broadley, D Clayton, A Compston.   

Abstract

OBJECTIVES: To assess the potential contribution of genetic factors to clinical phenotype in multiple sclerosis.
METHODS: Using a cohort of 262 pairs of coaffected siblings from 250 families with multiple sclerosis, intersibling concordance analysis was used to explore underlying genetic mechanisms in disease pathogenesis by assessing parameters of disease course, clinical presentation, age and year of onset, and measures of disability and handicap.
RESULTS: Adjusted intraclass correlation coefficients were not significant for either age of onset or for year of first symptom. One third of sibling pairs were concordant for presenting symptom (81/262), a result that was non-significant. However, course type was identical in 50% of the sibling pairs (kappa=0.17 (95% confidence interval (95% CI) 0.08 to 0.26)) indicating a significant result. Severity of the disease at assessment, using the Kurtzke and CAMBS scales, demonstrated that whereas there was no agreement for relapse rate in the previous year within the sibship, there was significant concordance for measures of disability (kappa=0.11 (95% CI 0.04 to 0.19)), progression (kappa=0.09 (95% CI 0.01 to 0.18)) and handicap (kappa=0.08 (95% CI 0.02 to 0.14)).
CONCLUSIONS: Within a sibship, the clinical presentation tends to be different. However, once established, concordance is more likely to be seen for the ultimate course, leading in the end to similar disability and handicap scores. These results are consistent with the hypothesis that genes influence both disease susceptibility and evolution in multiple sclerosis.

Entities:  

Mesh:

Year:  2001        PMID: 11723196      PMCID: PMC1737661          DOI: 10.1136/jnnp.71.6.757

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  Familial and conjugal multiple sclerosis.

Authors:  K SCHAPIRA; D C POSKANZER; H MILLER
Journal:  Brain       Date:  1963-06       Impact factor: 13.501

2.  EDMUS, a European database for multiple sclerosis.

Authors:  C Confavreux; D A Compston; O R Hommes; W I McDonald; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

3.  Multiple sclerosis sibling pairs: clustered onset and familial predisposition.

Authors:  T H Doolittle; R H Myers; J R Lehrich; G Birnbaum; W Sheremata; G M Franklin; L M Nelson; S L Hauser
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

4.  Age of onset in siblings concordant for multiple sclerosis.

Authors:  D E Bulman; A D Sadovnick; G C Ebers
Journal:  Brain       Date:  1991-04       Impact factor: 13.501

Review 5.  An epidemiological study of multiple sclerosis. Familial aggregation social determinants, and exogenic factors.

Authors:  N Koch-Henriksen
Journal:  Acta Neurol Scand Suppl       Date:  1989

6.  HLA typing in the United Kingdom multiple sclerosis genome screen.

Authors:  F Coraddu; S Sawcer; R Feakes; J Chataway; S Broadley; H B Jones; D Clayton; J Gray; S Smith; C Taylor; P N Goodfellow; A Compston
Journal:  Neurogenetics       Date:  1998-12       Impact factor: 2.660

7.  Genetic analysis of multiple sclerosis in Orkney.

Authors:  D F Roberts; M J Roberts; D C Poskanzer
Journal:  J Epidemiol Community Health       Date:  1979-12       Impact factor: 3.710

8.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

9.  Problems with rating scales for multiple sclerosis: a novel approach--the CAMBS score.

Authors:  C J Mumford; A Compston
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

10.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

View more
  8 in total

Review 1.  Genetic analysis of multiple sclerosis.

Authors:  Alastair Compston; Stephen Sawcer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

2.  Analysing the effect of candidate genes on complex traits: an application in multiple sclerosis.

Authors:  Tineke Hooper-van Veen; Johannes Berkhof; Chris H Polman; Bernard M J Uitdehaag
Journal:  Immunogenetics       Date:  2006-04-13       Impact factor: 2.846

3.  Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Gabriele C Deluca; Katie M Morrison; Blanca M Herrera; David A Dyment; Matthew R Lincoln; Sarah-Michelle Orton; Michael J Chao; Alexandra Degenhardt; Maura Pugliatti; A Dessa Sadovnick; Stefano Sotgiu; George C Ebers
Journal:  J Neurol       Date:  2008-06-20       Impact factor: 4.849

4.  Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease.

Authors:  James C Lee; Daniele Biasci; Rebecca Roberts; Richard B Gearry; John C Mansfield; Tariq Ahmad; Natalie J Prescott; Jack Satsangi; David C Wilson; Luke Jostins; Carl A Anderson; James A Traherne; Paul A Lyons; Miles Parkes; Kenneth G C Smith
Journal:  Nat Genet       Date:  2017-01-09       Impact factor: 41.307

Review 5.  The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy.

Authors:  Peter O Behan; Abhijit Chaudhuri
Journal:  Inflammopharmacology       Date:  2010-09-24       Impact factor: 5.093

Review 6.  Genetic epidemiology and Mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges.

Authors:  Lavinia Paternoster; Kate Tilling; George Davey Smith
Journal:  PLoS Genet       Date:  2017-10-05       Impact factor: 5.917

7.  Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.

Authors:  Xiaoming Jia; Lohith Madireddy; Stacy Caillier; Adam Santaniello; Federica Esposito; Giancarlo Comi; Olaf Stuve; Yuan Zhou; Bruce Taylor; Trevor Kilpatrick; Filippo Martinelli-Boneschi; Bruce A C Cree; Jorge R Oksenberg; Stephen L Hauser; Sergio E Baranzini
Journal:  Ann Neurol       Date:  2018-07-03       Impact factor: 10.422

Review 8.  Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis.

Authors:  Hans Lassmann
Journal:  Front Immunol       Date:  2019-01-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.